Neurostimulation for the Treatment of Post-Stroke Aphasia
ConditionPost-stroke Aphasia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorQVITI S.A.
About this trial
The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
Eligibility criteria
Qualifiers
diagnosis of aphasia: Broca's or mixed (based on the assessment of a Speech Language Pathologist).
presence of a focus of injury in the left hemisphere (within one hemisphere only) as a result of the first ischemic or hemorrhagic stroke (based on CT/MRI examination);
chronic stage of the disease - time since the stroke occurred over 6 months.
ability to achieve an accuracy in the Naming Task of 10-60%.
Disqualifiers
severe cognitive, auditory or visual impairment that would preclude cognitive and language testing - inability to follow a two-step command.
presence of metal implants in the skull.
presence of major untreated or unstable psychiatric disease.
history of epilepsy or seizures.
Trial design
Treatments tested in this trial
- tACS
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
QVITI S.A.
Lead sponsor
Icahn School of Medicine at Mount Sinai
Collaborator
Source ClinicalTrials.gov